Search Results
JCAR017 for B-Cell NHL
Safety Profile of CAR-T Cell JCAR017 in R/R Aggressive B-NHL patients
Results of the TRANSCEND study of CAR T Cell Product JCAR017 in patients with R/R aggressive B-NHL
Dr. Abramson on TRANSCEND on JCAR017 Therapy in NHL
Liso-cel for aggressive B-cell NHL
Liso-cel for second-line R/R aggressive large B-cell NHL
Dr. Maloney on CAR T-Cell Product in B-Cell Lymphoma
Transcend NHL 001: liso-cel in R/R B-cell NHL
Dr. Abramson on the TRANSCEND NHL 001 Trial in Large B-Cell Lymphoma
Mosunetuzumab in B-NHL R/R to CAR-T
Dr. Maloney Discusses Response to JCAR017 CAR T-Cell Therapy
Finding the expansion balance: CAR T-cell response markers identified from the trial of JCAR017
